<!-- BEGIN: main -->
<!DOCTYPE html>
<html>
<head>
<title>Medicine Safety Code</title>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<link rel="stylesheet"
	href="css/themes/default/jquery.mobile-1.3.2.min.css">
<link rel="stylesheet" href="_assets/css/jqm-demos.css">
<link rel="shortcut icon" href="images/favicon.ico">
<link rel="stylesheet" href="http://fonts.googleapis.com/css?family=Open+Sans:300,400,700">
<link rel="stylesheet" href="css/safety-code.css">
<script src="js/jquery.js"></script>
<script src="_assets/js/index.js"></script>
<script src="js/jquery.mobile-1.3.2.min.js"></script>
</head>
<body>

	<div data-role="page" class="jqm-demos">

		<div data-role="header" class="jqm-header"
			style="text-align: center; padding: 3px">
			<img src="images/safety-code-logo.png" width="209" height="30"
				alt="safety-code.org" />
		</div>

		<div data-role="content" class="jqm-content">
			
			<p>Matching recommendations for <b>azathioprine</b> are shown below. Recommendations are based on assuming <b>TPMT*1, TPMT*3A</b></p>
			<fieldset style="margin-bottom:20px">
				<legend>Recommendation</legend>
				<p class="ui-bar ui-bar-e">If disease treatment normally starts at the "full dose", consider starting at 30-70% of target dose (e.g., 1-1.5 mg/kg/d), and titrate based on tolerance. Allow 2-4 weeks to reach steady state after each dose adjustment.</p>
				<p class="ui-bar">Source: Clinical Pharmacogenetics Implementation Consortium <a href="http://www.pharmgkb.org/drug/PA448515" data-role="button" data-mini="true" data-inline="true" data-icon="info" target="_blank">show source</a><br/>
				Last update of guideline: January 2013</p>
			</fieldset>
			
			<fieldset style="margin-bottom:20px">
				<legend>Recommendation</legend>
				<p class="ui-bar ui-bar-e">Select alternative drug or reduce dose by 50%. Increase dose in response of hematologic monitoring and efficacy.</p>
				<p class="ui-bar">Source: Dutch Pharmacogenetics Working Group <a href="http://www.pharmgkb.org/guideline/PA166104934" data-role="button" data-mini="true" data-inline="true" data-icon="info" target="_blank">show source</a><br/>
				Last update of guideline: May 2011</p>
			</fieldset>
			
		</div>

	<div data-role="footer" style="text-align: center; padding: 5px;">
		<div>
			This service is provided for research purposes only and comes without
			any warranty. (C)&nbsp;2013&nbsp;<a href="http://safety-code.org/"
				data-ajax="false">safety-code.org</a>
		</div>
	</div>
	</div>
</body>
</html>
<!-- END: main -->